Stock AGN ALGERNON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Algernon Pharmaceuticals Inc.

Equities

AGN

CA01559R4008

Market Closed - Canadian Securities Exchange
Other stock markets
 14:58:15 2024-06-21 EDT 		5-day change 1st Jan Change
0.12 CAD 0.00% Intraday chart for Algernon Pharmaceuticals Inc. -7.69% +84.62%
04-30 Algernon Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
04-10 Algernon Pharmaceuticals Inc. announced that it has received CAD 0.017 million in funding CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ALGERNON PHARMACEUTICALS INC. Stock Algernon Pharmaceuticals Inc.
 1.92M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 114B
ARGENX SE Stock argenx SE
 23.61B -
BIONTECH SE Stock BioNTech SE
 20.43B -
GENMAB A/S Stock Genmab A/S
 16.55B
  1. Stock Market
  2. Equities
  3. AGN Stock
  4. Charts Algernon Pharmaceuticals Inc.
  5. Sector Chart